CRYO CELL INTERNATIONAL INC (CCEL) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-05-08

Key Insights

Cryo-Cell received notice that NYSE Regulation accepted its compliance plan, allowing the company to remain listed on NYSE American through a plan period ending September 9, 2027, avoiding immediate delisting.
The company must regain full compliance with NYSE American continued listing standards by the September 9, 2027 deadline or face potential delisting proceedings, representing significant execution risk over the next 16 months.
NYSE Regulation's acceptance indicates the company's remediation strategy was deemed viable, but the stock will remain under heightened scrutiny with periodic reviews during the plan period, creating continued uncertainty for investors.

Want the newest filings?

This analysis covers the filing from 2026-05-08. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-03-12

Cryo-Cell International has received a notice from NYSE American indicating that the company is not in compliance with certain continued listing standards, which could result in delisting if the issue is not resolved.
The company has until April 8, 2026, to submit a plan to NYSE American outlining how it intends to regain compliance, but there is no assurance that the plan will be accepted or that the company will be able to regain compliance within the allotted time frame.
The company's common stock will continue to trade on the NYSE American under the symbol 'CCEL' while the company pursues a plan to regain compliance, but a delisting could have a significant impact on the stock's liquidity and accessibility for investors.

Other reports for CRYO CELL INTERNATIONAL INC

Quarterly Report Annual Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.